Save the New Tetracycline Omadacycline (Nuzyra) as a Last Resort
You'll see a new, once-daily, IV and PO tetracycline antibiotic, omadacycline (Nuzyra, noo-ZYE-rah).
It's approved for community-acquired pneumonia (CAP)...or skin infections, including methicillin-resistant Staph aureus (MRSA).
Evidence suggests omadacycline is non-inferior to moxifloxacin for CAP or linezolid for skin infections. And omadacycline costs about $350/IV dose or $400/oral dose.